DK174229B1 - Antibiotisk reuterin - Google Patents

Antibiotisk reuterin Download PDF

Info

Publication number
DK174229B1
DK174229B1 DK198905428A DK542889A DK174229B1 DK 174229 B1 DK174229 B1 DK 174229B1 DK 198905428 A DK198905428 A DK 198905428A DK 542889 A DK542889 A DK 542889A DK 174229 B1 DK174229 B1 DK 174229B1
Authority
DK
Denmark
Prior art keywords
reuterin
glycerol
reuteri
lactobacillus
agent
Prior art date
Application number
DK198905428A
Other languages
Danish (da)
English (en)
Other versions
DK542889A (da
DK542889D0 (da
Inventor
Walter J Dobrogosz
Sven E Lindgren
Original Assignee
Biogaia Biolog Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Biolog Ab filed Critical Biogaia Biolog Ab
Publication of DK542889A publication Critical patent/DK542889A/da
Publication of DK542889D0 publication Critical patent/DK542889D0/da
Application granted granted Critical
Publication of DK174229B1 publication Critical patent/DK174229B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198905428A 1987-05-01 1989-10-31 Antibiotisk reuterin DK174229B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4602787A 1987-05-01 1987-05-01
US4602787 1987-05-01
US10283087A 1987-09-22 1987-09-22
US10283087 1987-09-22
PCT/US1988/001423 WO1988008452A1 (en) 1987-05-01 1988-04-28 Antibiotic reuterin
US8801423 1988-04-28

Publications (3)

Publication Number Publication Date
DK542889A DK542889A (da) 1989-10-31
DK542889D0 DK542889D0 (da) 1989-10-31
DK174229B1 true DK174229B1 (da) 2002-10-07

Family

ID=26723487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198905428A DK174229B1 (da) 1987-05-01 1989-10-31 Antibiotisk reuterin

Country Status (10)

Country Link
EP (2) EP0698347B1 (de)
JP (2) JP3007092B2 (de)
AT (2) ATE332649T1 (de)
AU (1) AU620807B2 (de)
CA (1) CA1314255C (de)
DE (2) DE3856591D1 (de)
DK (1) DK174229B1 (de)
FI (2) FI895197A0 (de)
NO (2) NO301430B1 (de)
WO (1) WO1988008452A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198425A (en) * 1989-08-30 1993-03-30 Bio-Mega, Inc. Inhibitors of bacterial ribonucleotide reductase
JP3172181B2 (ja) * 1991-01-28 2001-06-04 バイオガイア・バイオロジクス・エイビー 家禽にｉｎ ｏｖｏで直接供給微生物をデリバリーする方法
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
GB9803424D0 (en) * 1998-02-18 1998-04-15 Pfizer Ltd Performance enhancement
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
ES2607988T3 (es) 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
EP2158813A1 (de) 2008-08-28 2010-03-03 Omya Development AG Stabilisierung von wässrigen Mineralpräparaten durch Reuterin
WO2010045367A1 (en) * 2008-10-14 2010-04-22 Dr Pepper/Seven Up, Inc. Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN104053766B (zh) * 2011-11-30 2016-05-04 热尔韦·达诺尼公司 产生罗伊氏菌素的短乳杆菌
WO2013155624A1 (en) * 2012-04-16 2013-10-24 Cascades Canada Ulc Antimicrobial compositions and uses thereof
EA201491272A1 (ru) * 2012-05-29 2015-10-30 Данута Кружевска Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применение
EP2674162A1 (de) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoprodukt, beinhaltend lactobacillus reuteri dan080, zur verwendung bei der prophylaxe, diagnose sowie bei der medizinischen and veterinärmedizinischen behandlung
EP3033351A4 (de) * 2013-08-12 2017-03-22 Mansel Griffiths Antivirale verfahren und zusammensetzungen mit probiotischen bakteriellen molekülen
ITUB20152987A1 (it) * 2015-08-07 2017-02-07 Minaba Tech S R L Procedimento di bio-conservazione di prodotti ittici e relativi prodotti
CN105340974B (zh) * 2015-10-30 2018-01-09 湖北省生物农药工程研究中心 一种生物拌种剂及应用
CN114806929B (zh) * 2022-03-29 2023-10-31 山东凤凰生物科技股份有限公司 一株高产罗伊氏菌素的罗伊氏乳杆菌lr4009及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687981A (en) * 1968-01-17 1972-08-29 Du Pont Process for making a dioxane
US4053638A (en) * 1970-05-06 1977-10-11 William Wrigley Jr. Company Anticaries confectioneries and oral health products
JPS60116369U (ja) 1984-01-11 1985-08-06 リョービ株式会社 ゴルフクラブメタルヘツド
US10283087B2 (en) 2016-06-15 2019-05-07 Sk Planet Co., Ltd. Digital signage device and method for operating the same

Also Published As

Publication number Publication date
EP0357673A4 (en) 1991-09-25
AU1724588A (en) 1988-12-02
DE3856591D1 (de) 2006-08-24
FI895197A0 (fi) 1989-11-01
NO308982B1 (no) 2000-11-27
DK542889A (da) 1989-10-31
ATE332649T1 (de) 2006-08-15
NO963930L (no) 1989-02-28
EP0698347A3 (de) 1999-09-08
JPH02503385A (ja) 1990-10-18
JPH11137292A (ja) 1999-05-25
DK542889D0 (da) 1989-10-31
EP0698347B1 (de) 2006-07-12
AU620807B2 (en) 1992-02-27
WO1988008452A1 (en) 1988-11-03
NO885833L (no) 1989-02-28
NO301430B1 (no) 1997-10-27
CA1314255C (en) 1993-03-09
JP3244659B2 (ja) 2002-01-07
DE3855664D1 (de) 1996-12-19
FI110366B (fi) 2002-12-31
DE3855664T2 (de) 1997-03-20
ATE145243T1 (de) 1996-11-15
NO885833D0 (no) 1988-12-30
NO963930D0 (no) 1996-09-19
EP0357673B1 (de) 1996-11-13
EP0698347A2 (de) 1996-02-28
JP3007092B2 (ja) 2000-02-07
EP0357673A1 (de) 1990-03-14
FI960543A (fi) 1996-02-06
FI960543A0 (fi) 1996-02-06

Similar Documents

Publication Publication Date Title
DK174229B1 (da) Antibiotisk reuterin
US5849289A (en) Method for inhibiting microorganism growth
Chung et al. In vitro studies on reuterin synthesis by Lactobacillus reuteri
He et al. Microbial transformation of deoxynivalenol (vomitoxin)
Shima et al. Novel detoxification of the trichothecene mycotoxin deoxynivalenol by a soil bacterium isolated by enrichment culture
Ultee et al. Influence of carvacrol on growth and toxin production by Bacillus cereus
AU693146B2 (en) Probiotic for control of (salmonella)
US5352586A (en) Method of determining the presence of an antibiotic produced by Lactobacillus reuteri
Nieto-Penalver et al. Gluconic acid produced by Gluconacetobacter diazotrophicus Pal5 possesses antimicrobial properties
Nadathur et al. Antimutagenicity of fermented milk
Hashidoko et al. Decarboxylative conversion of hydroxycinnamic acids by Klebsiella oxytoca and Erwinia uredovora, epiphytic bacteria of Polymnia sonchifolia leaf, possibly associated with formation of microflora on the damaged leaves
Osawa et al. Metabolism of tannin-protein complex by facultatively anaerobic bacteria isolated from koala feces
KR101697535B1 (ko) 복분자로부터 분리한 락토바실러스 플란타룸 균주 및 이를 포함하는 식품 조성물
Nallala et al. Probiotic evaluation of antimicrobial Lactobacillus plantarum VJC38 isolated from the crop of broiler chicken
KR100769299B1 (ko) 알코올 분해능이 있는 유산균 및 그를 함유하는 유제품, 건강 기능성 식품 및 식품 첨가제
Rolin et al. 13 C-NMR study of lactate metabolism in Propionibacterium freudenreichii subsp. shermanii
Durant et al. Comparison of Batch Culture Growth and Fermentation of a PoultryVeillonellaIsolate and SelectedVeillonellaSpecies Grown in a Defined Medium
Osman Factors affecting the antifungal properties of Brevibacterium linens
Hasegawa et al. Bladder freeze ulceration and sodium saccharin feeding in the rat: examination for urinary nitrosamines, mutagens and bacteria, and effects on hepatic microsomal enzymes
Durant et al. Response of selected poultry cecal probiotic bacteria and a primary poultry Salmonella typhimurium isolate grown with or without glucose in liquid batch culture
Kole et al. Bovine bile resistance increases Leuconostoc oenos 44.40 viability upon lyophilization
Begunova et al. Optimization of Cultivation Conditions for the Lactobacillus reuteri LR1 Strain to Improve the Biosynthesis of Bacteriocin-Like Substances
Marinkova et al. Antimicrobial activity of Bulgarian products and their extracts containing bioactive components
Watanabe Studies on gut bacterial metabolisms of food-derived bioactive phytochemicals
CN117598439A (zh) 一种用于生产泡椒凤爪以及提高其货架期的方法

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired